Cargando…

Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke

PURPOSE: Several studies have examined the clinical impact of poststroke and stroke-related sarcopenia on stroke recovery. However, few studies have investigated the effect of sarcopenia detected shortly after stroke on functional prognosis. We predicted functional outcomes using early screening for...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang-Hun, Choi, Hangseok, Kim, Keon-Yeup, Lee, Hyung-Soo, Jung, Jin-Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329446/
https://www.ncbi.nlm.nih.gov/pubmed/37427011
http://dx.doi.org/10.2147/CIA.S402548
_version_ 1785070020638801920
author Lee, Sang-Hun
Choi, Hangseok
Kim, Keon-Yeup
Lee, Hyung-Soo
Jung, Jin-Man
author_facet Lee, Sang-Hun
Choi, Hangseok
Kim, Keon-Yeup
Lee, Hyung-Soo
Jung, Jin-Man
author_sort Lee, Sang-Hun
collection PubMed
description PURPOSE: Several studies have examined the clinical impact of poststroke and stroke-related sarcopenia on stroke recovery. However, few studies have investigated the effect of sarcopenia detected shortly after stroke on functional prognosis. We predicted functional outcomes using early screening for sarcopenia in patients with acute ischemic stroke. We also examined the effect of sarcopenia detected shortly after stroke on functional prognosis. PATIENTS AND METHODS: Patients diagnosed with acute ischemic stroke within 2 days of symptom onset were consecutively enrolled at a tertiary university hospital. Appendicular skeletal muscle mass (ASM) was measured using dual-energy X-ray absorptiometry during early hospitalization. Sarcopenia was diagnosed based on low ASM and strength criteria of the Asian Working Group for Sarcopenia (AWGS) and European Working Group on Sarcopenia in Older People (EWGSOP2). The primary outcome was poor functional outcome, defined as a modified Rankin score of 4–6 and all-cause mortality at 3 months. RESULTS: Of the 653 patients, 214 (32.8%) and 174 (26.6%) had sarcopenia according to the AWGS and EWGSOP2 criteria, respectively. Irrespective of the definition, the sarcopenia group had a significantly higher proportion of patients with poor functional outcomes and all-cause mortality. Multivariate logistic regression analysis revealed that height-adjusted ASM was independently associated with poor functional outcomes (odds ratio: 0.61; 95% confidence interval: 0.40–0.91; P <0.005), and they were negatively correlated. However, the association between 3-month mortality, skeletal muscle mass, and sarcopenia was not sustained in multivariate analyses. CONCLUSION: Height-adjusted ASM associated with sarcopenia is a potential predictor of poor functional outcomes at 3 months in patients with acute stroke. However, owing to the limitations of this study, further research is required to confirm these findings.
format Online
Article
Text
id pubmed-10329446
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103294462023-07-09 Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke Lee, Sang-Hun Choi, Hangseok Kim, Keon-Yeup Lee, Hyung-Soo Jung, Jin-Man Clin Interv Aging Original Research PURPOSE: Several studies have examined the clinical impact of poststroke and stroke-related sarcopenia on stroke recovery. However, few studies have investigated the effect of sarcopenia detected shortly after stroke on functional prognosis. We predicted functional outcomes using early screening for sarcopenia in patients with acute ischemic stroke. We also examined the effect of sarcopenia detected shortly after stroke on functional prognosis. PATIENTS AND METHODS: Patients diagnosed with acute ischemic stroke within 2 days of symptom onset were consecutively enrolled at a tertiary university hospital. Appendicular skeletal muscle mass (ASM) was measured using dual-energy X-ray absorptiometry during early hospitalization. Sarcopenia was diagnosed based on low ASM and strength criteria of the Asian Working Group for Sarcopenia (AWGS) and European Working Group on Sarcopenia in Older People (EWGSOP2). The primary outcome was poor functional outcome, defined as a modified Rankin score of 4–6 and all-cause mortality at 3 months. RESULTS: Of the 653 patients, 214 (32.8%) and 174 (26.6%) had sarcopenia according to the AWGS and EWGSOP2 criteria, respectively. Irrespective of the definition, the sarcopenia group had a significantly higher proportion of patients with poor functional outcomes and all-cause mortality. Multivariate logistic regression analysis revealed that height-adjusted ASM was independently associated with poor functional outcomes (odds ratio: 0.61; 95% confidence interval: 0.40–0.91; P <0.005), and they were negatively correlated. However, the association between 3-month mortality, skeletal muscle mass, and sarcopenia was not sustained in multivariate analyses. CONCLUSION: Height-adjusted ASM associated with sarcopenia is a potential predictor of poor functional outcomes at 3 months in patients with acute stroke. However, owing to the limitations of this study, further research is required to confirm these findings. Dove 2023-07-04 /pmc/articles/PMC10329446/ /pubmed/37427011 http://dx.doi.org/10.2147/CIA.S402548 Text en © 2023 Lee et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lee, Sang-Hun
Choi, Hangseok
Kim, Keon-Yeup
Lee, Hyung-Soo
Jung, Jin-Man
Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke
title Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke
title_full Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke
title_fullStr Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke
title_full_unstemmed Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke
title_short Appendicular Skeletal Muscle Mass Associated with Sarcopenia as a Predictor of Poor Functional Outcomes in Ischemic Stroke
title_sort appendicular skeletal muscle mass associated with sarcopenia as a predictor of poor functional outcomes in ischemic stroke
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329446/
https://www.ncbi.nlm.nih.gov/pubmed/37427011
http://dx.doi.org/10.2147/CIA.S402548
work_keys_str_mv AT leesanghun appendicularskeletalmusclemassassociatedwithsarcopeniaasapredictorofpoorfunctionaloutcomesinischemicstroke
AT choihangseok appendicularskeletalmusclemassassociatedwithsarcopeniaasapredictorofpoorfunctionaloutcomesinischemicstroke
AT kimkeonyeup appendicularskeletalmusclemassassociatedwithsarcopeniaasapredictorofpoorfunctionaloutcomesinischemicstroke
AT leehyungsoo appendicularskeletalmusclemassassociatedwithsarcopeniaasapredictorofpoorfunctionaloutcomesinischemicstroke
AT jungjinman appendicularskeletalmusclemassassociatedwithsarcopeniaasapredictorofpoorfunctionaloutcomesinischemicstroke